Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2011Human VaccinesOpen Access

Molecular pharming

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMatthew J. PaulSt George's, University of LondonCDCraig J. van DolleweerdCallaghan InnovationPDPascal M. W. DrakeUniversity of London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Paul et al. (2011) studied this question.

synapsesocial.com/papers/6a14866cf32709f3ed8ef226https://doi.org/10.4161/hv.7.3.14456
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expanded impact of protein N-myristoylation in plants2008 · 26 citations
  2. 2The clinical picture of rabies in man1976 · 99 citations
  3. 3Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries.2002 · 284 citations
  4. 4pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants2009 · 871 citations
  5. 5HIV‐1 p24–immunoglobulin fusion molecule: a new strategy for plant‐based protein production2005 · 88 citations